《Proceedings of Anticancer Research》

作品数:546被引量:54H指数:2
导出分析报告
《Proceedings of Anticancer Research》
主办单位:Bio-Byword Scientific Publishing澳大利亚百图科学出版社
最新期次:2025年2期更多>>
发文主题:TREATMENTPATIENTSLINESAUTHOR_GUIDEPROCESS更多>>
发文领域:医药卫生文化科学自动化与计算机技术经济管理更多>>
发文基金:国家自然科学基金广西壮族自治区自然科学基金上海市自然科学基金河北省自然科学基金更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
A Review of the Relationship between Tea Drinking and Breast Cancer
《Proceedings of Anticancer Research》2025年第2期1-19,共19页Jingjing Yu Suriyakala Perumal Chandran Farra Aidah Jumuddin Nurul Azmir Amir Hashim 
The global incidence of breast cancer remains high and is increasing annually in some regions.Despite the variety of current treatments for breast cancer,the preventive and therapeutic effects are still limited due to...
关键词:Tea drinking Breast cancer RISK PROGNOSIS Green tea Black tea 
Construction of an Evidence-based Practice Protocol for Perioperative Nutritional Optimization in Esophageal Cancer Patients
《Proceedings of Anticancer Research》2025年第2期20-26,共7页Tingting Li Yonghui Li 
Objective:To construct an evidence-based practice plan for perioperative nutritional optimization in esophageal cancer patients.Methods:By systematically searching relevant guidelines at home and abroad,two experts in...
关键词:Esophageal cancer Perioperative care Nutritional care Evidence-based care Assessment Health education COMPLICATIONS 
Advances and Challenges in mRNA Vaccine Technology
《Proceedings of Anticancer Research》2025年第2期27-42,共16页Ying Zhou Zhaoru Wu Yibo Wang Rongkang Lao Yunfei Huang Shun Li Qiang Fu Jiedan Liao 
National Natural Science Foundation of Guangdong Province(No.2022A1515140052);Project of Science and Technology of Guangdong Province(No.KTP20240768);Project of Department of Education of Guangdong Province(No.2022ZDJS036)。
Since the outbreak of COVID-19,mRNA vaccine technology has achieved groundbreaking advancements.Characterized by its high safety profile and potent immune activation capabilities,this technology has demonstrated signi...
关键词:mRNA vaccine Molecular design Delivery systems Immune mechanisms 
Research Progress of EZH2 in Tumors and Translational Perspectives
《Proceedings of Anticancer Research》2025年第2期43-55,共13页Yu Tian Hu-Li Li You-Fu Pan 
supported by the National Natural Science Foundation of China(32360166,31760321).
Enhancer of zeste homolog 2(EZH2)is a key epigenetic regulatory protein and enzyme catalytic subunit of the polycomb repressor complex 2(PRC2),responsible for catalyzing the trimethylation of histone H3K27 and subsequ...
关键词:EZH2 Polycomb repressor complex 2 Cell signaling INHIBITOR 
Antioxidant Protective Effect of Melatonin on Cyclophosphamide-Induced Premature Ovarian Failure and its Mechanism
《Proceedings of Anticancer Research》2025年第2期56-70,共15页Chongran Liu Tongtong Wei Xinyue Rao Ziqi Fan Minghui Hao Wanjing Wang Yihang Song 
2023 Special Project for Serving the National Development Strategy with Basic Scientific Research Fees from Central Universities(No.31920230188);2023 Northwestern Minzu University College-Level Innovation and Entrepreneurship Training Program(No.X202310742289);2024 National College Students’Innovation and Entrepreneurship Training Program(No.202410742005)。
Objective:To study the antioxidant protective effect and mechanism of melatonin on cyclophosphamide-induced premature ovarian failure model mice.Methods:Six-month sexually mature female Kunming mice were taken for one...
关键词:MELATONIN CYCLOPHOSPHAMIDE Premature ovarian failure ANTIOXIDATION 
Analysis of the Clinical Effect of Pulmicort Respules Inhalation Combined with Cetirizine in the Treatment of Pediatric Asthma and its Influence on Inflammatory Factors in Children
《Proceedings of Anticancer Research》2025年第2期71-76,共6页Yong Peng Aimin Li 
Objective:To analyze the clinical value of Pulmicort Respules inhalation combined with cetirizine in the treatment of pediatric asthma.Methods:From December 2023 to December 2024,82 children with asthma admitted to ou...
关键词:Pulmicort Respules CETIRIZINE Pediatric asthma Inflammatory factors 
Epidemiological Analysis of 9,064 Cases of Non-Hodgkin Lymphoma
《Proceedings of Anticancer Research》2025年第2期77-82,共6页Li Liu Zhen Ruan 
Objective:This study aimed to investigate the epidemiological characteristics and treatment regimens of non-Hodgkin lymphoma(NHL)in China through a retrospective analysis of 9,064 NHL cases.Methods:Clinical data of 9,...
关键词:Non-Hodgkin lymphoma EPIDEMIOLOGY Treatment regimen 
The Spatial Location of Chromosomes in Dividing Cells and the Relative Stability of Chromosome Spatial Structure
《Proceedings of Anticancer Research》2025年第2期83-91,共9页Chunxiao Wu Dongyun Jiang Tao Jiang Luxia Xu Qian Xu Meng Zhao Qin Zhu ZhigangGuo Jinlan Pan Suning Chen 
The stability and evolution of human genetics depend on chromosomes and chromosome-chromosome interactions.We wish to understand the spatial location of chromosomes in dividing cells in order to understand the relatio...
关键词:CHROMOSOME Human genetics Chromosome territory 3D-FISH 
The Predictive Value of SPP1 Gene Expression for the Survival of Advanced Liver Cancer Treated with Transarterial Chemoembolization
《Proceedings of Anticancer Research》2025年第1期97-107,共11页Yu Cai Pu Yan Chang Tian Yuqing Li Yuanyuan Jia Siqi Wang 
Medical Research Project of Xi’an Science and Technology Bureau“Molecular Mechanism of miR-1305 Competitive Endogenous circRNA in the Development of Liver Cancer”(Project No.22YXYJ0134);General Project of Key Research and Development Program of Shaanxi Provincial Department of Science and Technology“Mechanism Study on the Inhibition of Liver Cancer Invasion and Metastasis by Downregulating METTL3 and Reducing the m6A Modification Level of MMP3 with Honokiol”(Project No.2023-YBSF-631)。
Objective:To evaluate the predictive value of secreted phosphoprotein 1(SPP1)gene expression for postoperative survival in patients with advanced liver cancer undergoing hepatic artery interventional chemoembolization...
关键词:SPP1 Transarterial chemoembolization Advanced liver cancer Survival period Predictive value 
Clinical Efficacy and Safety Analysis of Toripalimab Combined with GC Chemotherapy for Advanced Urothelial Carcinoma
《Proceedings of Anticancer Research》2025年第1期108-114,共7页Song Xue Dongli Ruan 
Objective:To analyze the clinical efficacy and safety of toripalimab combined with the GC chemotherapy regimen in the treatment of advanced urothelial carcinoma.Methods:A retrospective study was conducted on 102 patie...
关键词:Urothelial carcinoma Toripalimab CHEMOTHERAPY SURVIVAL EFFICACY Safety 
检索报告 对象比较 聚类工具 使用帮助 返回顶部